Aprotinin treatment against SARS‐CoV‐2: A randomized phase III study to evaluate the safety and efficacy of a pan‐protease inhibitor for moderate COVID‐19-Reference-Cited by-同舟云学术

Aprotinin treatment against SARS‐CoV‐2: A randomized phase III study to evaluate the safety and efficacy of a pan‐protease inhibitor for moderate COVID‐19

Published:2022-04-05 Issue:6 Volume:52 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Redondo‐Calvo Francisco Javier¹²³^ORCID,Padín Juan Fernando⁴^ORCID,Muñoz‐Rodríguez José Ramón²³^ORCID,Serrano‐Oviedo Leticia³^ORCID,López‐Juárez Pilar³^ORCID,Porras Leal María Lourdes⁵,González Gasca Francisco Javier²⁵^ORCID,Rodríguez Martínez Marta⁶,Pérez Serrano Raúl⁶,Sánchez Cadena Abraham⁶^ORCID,Bejarano‐Ramírez Natalia²⁷^ORCID,Muñoz Hornero Constanza⁸^ORCID,Barberá Farré José Ramón⁹^ORCID,Domínguez‐Quesada Inmaculada⁹,Sepúlveda Berrocal María A.¹⁰,Villegas Fernández‐Infantes María Dolores⁵,Manrique Romo María Isabel⁵,Parra Comino Ángel⁴,Pérez‐Ortiz José Manuel²³^ORCID,Gómez‐Romero Francisco Javier²³^ORCID,García Pérez AM,Palomino Muñoz T,Espinosa Justo I,Ventura López P,Cosmen‐Sánchez A,Martínez Manzanal R,Asenjo Villamayor A,Loras Gallego C,Alcañiz Octavio I,Palma Bermejo N,Andrés Navarro N,Lizcaino Lizcanino A,Cano Llorente V,Prado Narciso R,Hoyos Mohedano J,Moya Gómez P,Bodoque‐Villar R,Pulido‐Sánchez G,Illescas Fernández‐Bermejo MS,Martínez Alarcón J,

Affiliation:

1. Department of Anesthesiology and Critical Care Medicine University General Hospital Ciudad Real Spain

2. Department of Medical Sciences (Pharmacology) School of Medicine at Ciudad Real University of Castilla‐La Mancha Ciudad Real Spain

3. School of Medicine at Ciudad Real University of Castilla‐La Mancha Ciudad Real Spain

4. Translational Research Unit University General Hospital of Ciudad Real Ciudad Real Spain

5. Department of Internal Medicine University General Hospital of Ciudad Real Ciudad Real Spain

6. Department of Pharmacy University General Hospital of Ciudad Real Ciudad Real Spain

7. Department of Paediatrics University General Hospital of Ciudad Real Ciudad Real Spain

8. Department of Internal Medicine General Hospital of Puertollano Puertollano Spain

9. Department of Internal Medicine University General Hospital of Alcazar de San Juan Alcazar de San Juan Spain

10. Department of Internal Medicine University General Hospital of Toledo Toledo Spain

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13776

Reference35 articles.

1. Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study

2. T cell immunobiology and cytokine storm of COVID‐19

3. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

4. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort

5. Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses;Virology;2024-12

2. Liposome-encapsulated aprotinin biodistribution in mice: Side-by-side comparison with free drug formulation;Biochemical and Biophysical Research Communications;2024-11

3. Activin A Is a Master Regulator of Phenotypic Switch in Adipose Stromal Cells Initiated by Activated Immune Cell-Secreted Interleukin-1β;Stem Cells and Development;2024-08-01

4. Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions;International Journal of Molecular Sciences;2024-06-29

5. Individual Patient Data Meta-Analysis evaluating Camostat Mesilate to Treat COVID-19 in Community Settings;2024-05-17